Home » Reports » Broker Ratings » GlaxoSmithKline plc 13.2% Potential Upside Indicated by Jefferies International
broker ratings

GlaxoSmithKline plc 13.2% Potential Upside Indicated by Jefferies International

GlaxoSmithKline plc using EPIC/TICKER code (LON:GSK) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘BUY’ today by analysts at Jefferies International. GlaxoSmithKline plc are listed in the Health Care sector within UK Main Market. Jefferies International have set their target price at 1725 GBX on its stock. This is indicating the analyst believes there is a potential upside of 13.2% from the opening price of 1523.2 GBX. Over the last 30 and 90 trading days the company share price has increased 26.4 points and decreased 44 points respectively. The 1 year high stock price is 1631.13 GBX while the 52 week low for the share price is 1179.39 GBX.

GlaxoSmithKline plc has a 50 day moving average of 1,547.52 GBX and the 200 Day Moving Average price is recorded at 1,472.56. There are currently 698,679,528 shares in issue with the average daily volume traded being 8,335,192. Market capitalisation for LON:GSK is £75,080,593,408 GBP.